Top Tweets for #ACONW

Aclarion @aclarioninc

almost 2 years ago

#Nociscan access is growing! We are thrilled to announce our commercial agreement with Sheraton Community Hospital, making Nociscan available to patients in greater Michigan with neurosurgeon John Keller #ACON #ACONW #nasdaq #spinesurgery #lowbackpain https://t.co/TlJHGuruBZ

aclarioninc's tweet photo. #Nociscan access is growing! We are thrilled to announce our commercial agreement with Sheraton Community Hospital, making Nociscan available to patients in greater Michigan with neurosurgeon John Keller #ACON #ACONW #nasdaq #spinesurgery #lowbackpain https://t.co/TlJHGuruBZ https://t.co/TxYpJJvBki

0

2

0

0

167

Aclarion @aclarioninc

about 2 years ago

Aclarion secures second payer coverage decision by Aviva, expanding Nociscan access to approximately 45% of patients with private payer insurance in the greater London area. https://t.co/Bb5bOwh52Q. #spinesurgery #spine #lowbackpain #nasdaq #ACON #ACONW

aclarioninc's tweet photo. Aclarion secures second payer coverage decision by Aviva, expanding Nociscan access to approximately 45% of patients with private payer insurance in the greater London area. https://t.co/Bb5bOwh52Q. #spinesurgery #spine #lowbackpain #nasdaq #ACON #ACONW https://t.co/4gszTRHPuA

0

4

1

0

129

Aclarion @aclarioninc

about 2 years ago

Excellent presentation yesterday by Dr. Lawrence Tannenbaum at ASNR on the topic of "AI Tools You Should Be Using." Honored to have Dr. Tannenbaum as a part of the Aclarion Medical Advisory Board. #ASNR2024 #ACON #ACONW #nasdaq #daytrading #medtechinvest #stocks #trading

aclarioninc's tweet photo. Excellent presentation yesterday by Dr. Lawrence Tannenbaum at ASNR on the topic of "AI Tools You Should Be Using." Honored to have Dr. Tannenbaum as a part of the Aclarion Medical Advisory Board. #ASNR2024 #ACON #ACONW #nasdaq #daytrading #medtechinvest #stocks #trading https://t.co/7fxozWNboq

0

2

0

0

61

Aclarion @aclarioninc

over 2 years ago

#ISASS24 is here! We’re excited to be at the conference this weekend. Reach out at [email protected] to connect in Miami and learn more about how Nociscan can help you pinpoint the source of chronic #lowbackpain. #ACON #ACONW #nasdaq #spine #pain #spinesurgery

aclarioninc's tweet photo. #ISASS24 is here! We’re excited to be at the conference this weekend. Reach out at info@aclarion.com to connect in Miami and learn more about how Nociscan can help you pinpoint the source of chronic #lowbackpain. #ACON #ACONW #nasdaq #spine #pain #spinesurgery https://t.co/3Nz7aCgn5b

0

2

0

0

222

Aclarion @aclarioninc

over 2 years ago

We are excited to announce that #Nociscan will be a part of the groundbreaking LIFEHAB trial in Norway. #ACON #ACONW #planetmicrocap #microcap #smallcap #medtechinvest #stocks #trading #daytrading #nasdaq #spine #lowbackpain #pain https://t.co/VZkQNkh2Zf

aclarioninc's tweet photo. We are excited to announce that #Nociscan will be a part of the groundbreaking LIFEHAB trial in Norway. #ACON #ACONW #planetmicrocap #microcap #smallcap #medtechinvest #stocks #trading #daytrading #nasdaq #spine #lowbackpain #pain https://t.co/VZkQNkh2Zf https://t.co/UhqOicDjPX

0

3

0

0

199

Aclarion @aclarioninc

over 2 years ago

We are excited to announce our strategic partnership agreement with Alphatec Spine. This agreement will unite the unique structural information powered by ATEC’s AlphaInformatiX platform with the innovative biomarker data of Aclarion’s Nociscan solution. #ACON #ACONW #nasdaq

aclarioninc's tweet photo. We are excited to announce our strategic partnership agreement with Alphatec Spine. This agreement will unite the unique structural information powered by ATEC’s AlphaInformatiX platform with the innovative biomarker data of Aclarion’s Nociscan solution.
#ACON #ACONW #nasdaq https://t.co/zwZBgbAHjz

0

3

2

0

263

Aclarion @aclarioninc

over 2 years ago

Aclarion is pleased to support the thought leadership at NYC-MISS where industry leading spine physicians advance the practice of spine care through enhanced diagnosis and personalized medicine. #ACON #ACONW #nasdaq #spinesurgery #NYCMISS

aclarioninc's tweet photo. Aclarion is pleased to support the thought leadership at NYC-MISS where industry leading spine physicians advance the practice of spine care through enhanced diagnosis and personalized medicine. #ACON #ACONW #nasdaq #spinesurgery #NYCMISS https://t.co/UwpGS2l1gJ

0

2

0

0

138

Aclarion @aclarioninc

almost 3 years ago

Aclarion website wins the American Digital Design Award from Graphic Design USA. Thank you @SprigConsulting and @WaltzCreative for developing the content and design to showcase our Nociscan solution. Visit our award-winning website https://t.co/t9LeQiRrCE #ACON #ACONW #nasdaq

aclarioninc's tweet photo. Aclarion website wins the American Digital Design Award from Graphic Design USA. Thank you @SprigConsulting and @WaltzCreative for developing the content and design to showcase our Nociscan solution. Visit our award-winning website https://t.co/t9LeQiRrCE #ACON #ACONW #nasdaq https://t.co/dXyuTGfZyC

0

4

3

0

218

Aclarion @aclarioninc

about 3 years ago

#Nociscan could save the US $239 - $441 million annually within the chronic low back pain population according to findings of the independent EVAL study from the UCSF. Learn more https://t.co/QYMrq4EhLG #ACON #ACONW #nasdaq #lowbackpain #spinesurgery

aclarioninc's tweet photo. #Nociscan could save the US $239 - $441 million annually within the chronic low back pain population according to findings of the independent EVAL study from the UCSF. Learn more https://t.co/QYMrq4EhLG
#ACON #ACONW #nasdaq #lowbackpain #spinesurgery https://t.co/5M1NuUVbAQ

0

3

0

0

96

Aclarion @aclarioninc

about 3 years ago

New and compelling healthcare economics data from the EVAL Study will be presented this week at #ISASS2023. Learn more about the initial findings of this pivotal economic analysis of #Nociscan for the treatment of #lowbackpain on Sat. June 3. #ACON #ACONW #nasdaq #spinesurgery

aclarioninc's tweet photo. New and compelling healthcare economics data from the EVAL Study will be presented this week at #ISASS2023. Learn more about the initial findings of this pivotal economic analysis of #Nociscan for the treatment of #lowbackpain on Sat. June 3. #ACON #ACONW #nasdaq #spinesurgery https://t.co/a0b2e9HMGG

0

3

1

0

124

Aclarion @aclarioninc

over 3 years ago

We’re excited to announce the publication of 2yr durability data demonstrating improved surgical outcomes for discogenic low back pain surgeries at chemically painful lumbar discs identified by Nociscan. https://t.co/XUKBoQRUAm #ACON #ACONW #spine #nociscan #lowbackpain #nasdaq

aclarioninc's tweet photo. We’re excited to announce the publication of 2yr durability data demonstrating improved surgical outcomes for discogenic low back pain surgeries at chemically painful lumbar discs identified by Nociscan. https://t.co/XUKBoQRUAm
#ACON #ACONW #spine #nociscan #lowbackpain #nasdaq https://t.co/qbq18gIbuy

0

3

1

0

140

Aclarion @aclarioninc

over 3 years ago

Aclarion team is excited to be at the Selby Spine conference with Sigurd Berven, Gregory Basil and Bob Eastlack. Working to unravel chronic low back pain complexity by improving clinical outcomes with objective analysis of critical pain bio markers. #ACON #ACONW #nasdaq #spine

aclarioninc's tweet photo. Aclarion team is excited to be at the Selby Spine conference with Sigurd Berven, Gregory Basil and Bob Eastlack. Working to unravel chronic low back pain complexity by improving clinical outcomes with objective analysis of critical pain bio markers.

#ACON #ACONW #nasdaq #spine https://t.co/mDJY7tmSAS

1

3

0

0

142

Aclarion @aclarioninc

over 3 years ago

Aclarion strengthens patent portfolio by addressing bacteria that can accelerate painful disc degeneration. Commercialization may give physicians better data to make critical decisions between antibiotic therapy or surgery. #ACON #ACONW #nasdaq https://t.co/jSrgApegb2

aclarioninc's tweet photo. Aclarion strengthens patent portfolio by addressing bacteria that can accelerate painful disc degeneration. Commercialization may give physicians better data to make critical decisions between antibiotic therapy or surgery. #ACON #ACONW #nasdaq https://t.co/jSrgApegb2 https://t.co/9F9o3ZvyuH

0

2

1

0

0

Aclarion @aclarioninc

almost 4 years ago

Sigurd Berven MD, Chief of Spine Service, Orthopaedic Surgery at UCSF is joining the effort to bring greater clarity to the diagnosis of discogenic pain as a key opinion leader through the Aclarion KOL program. https://t.co/5BTK28H4C9 #ACON #ACONW #nasdaq #spine

aclarioninc's tweet photo. Sigurd Berven MD, Chief of Spine Service, Orthopaedic Surgery at UCSF is joining the effort to bring greater clarity to the diagnosis of discogenic pain as a key opinion leader through the Aclarion KOL program. https://t.co/5BTK28H4C9
#ACON #ACONW #nasdaq #spine https://t.co/P0v9OovUMD

0

2

1

0

0

Aclarion @aclarioninc

almost 4 years ago

Aclarion will be at the LD Micro Conference Main Event on Tues Oct 25 at 9 AM PT in Los Angeles. Executive Chairman, Jeff Thramann will be presenting a company overview and business update Register here https://t.co/yHDWEgY5qC #ACON #ACONW #spine #spinesurgery #nasdaq #microcap

aclarioninc's tweet photo. Aclarion will be at the LD Micro Conference Main Event on Tues Oct 25 at 9 AM PT in Los Angeles. Executive Chairman, Jeff Thramann will be presenting a company overview and business update Register here https://t.co/yHDWEgY5qC

#ACON #ACONW #spine #spinesurgery #nasdaq #microcap https://t.co/ILKg5r7La3

0

4

1

0

0

Aclarion @aclarioninc

almost 4 years ago

Aclarion CEO Brent Ness met with Alpha Wolf host Tim Weintraut to discuss how Nociscan is uniquely positioned to address unmet needs in the spine market to help physicians better determine treatment strategies and improve patient outcomes. https://t.co/ySsdAhuDQx #ACON #ACONW

2

2

1

0

0

Aclarion @aclarioninc

almost 4 years ago

#Aclarion CEO Brent Ness was recently featured on Big Biz discussing how the Nociscan solution uniquely addresses the unmet clinical needs in the $134B low back and neck pain US market. Full interview here https://t.co/ySsdAhcuCp #ACON #ACONW #spinesurgery #backpain #NASDAQ

1

4

1

0

0

Aclarion @aclarioninc

almost 4 years ago

Nociscan selected for inclusion in pivotal NIH study for low back pain; Biomarkers for Evaluating Spine Treatments (BEST) Trial funded through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative. https://t.co/7zg88KQEWl #ACON #ACONW #spinesurgery #nasdaq

aclarioninc's tweet photo. Nociscan selected for inclusion in pivotal NIH study for low back pain; Biomarkers for Evaluating Spine Treatments (BEST) Trial funded through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative. https://t.co/7zg88KQEWl #ACON #ACONW #spinesurgery #nasdaq https://t.co/SWnYRWnxG2

0

2

2

0

0

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users